Physician profile
Sanjay Maniar
NPI 1417278714
$262,803.89
in general payments reported to CMS, 2019-2025
42 companies · $78K in 2025
The $78K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,414 · 2020: $3,199 · 2021: $768 · 2022: $63K · 2023: $54K · 2024: $58K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $169K · Travel and Lodging: $12K · Food and Beverage: $9,166 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $169,125.00 |
| Travel and Lodging | $11,564.78 |
| Food and Beverage | $9,166.42 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $193,829.13 | 2019-2025 | Watchman Access System, Watchman, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59,664.80 | 2019-2025 | Lifevest |
| Bracco Diagnostics INC. | $3,088.72 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $695.29 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $507.68 | 2019-2025 | Farxiga, Wainua |
| Irhythm Technologies, INC. | $472.49 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $415.19 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $376.57 | 2019-2024 | Xarelto |
| Amgen INC. | $376.37 | 2019-2025 | Repatha, Repatha |
| Heartflow, INC. | $340.93 | 2024-2025 | |
| Medtronic, INC. | $319.84 | 2021-2024 | Linq II |
| Abiomed | $295.74 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.03 | 2019-2025 | Jardiance |
| Abbott Laboratories | $271.98 | 2022-2025 | Assurity, Triclip, Jot Dx |
| Merck Sharp & Dohme LLC | $246.76 | 2022-2024 | Verquvo |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $212.35 | 2019-2021 | |
| Shockwave Medical, INC | $182.14 | 2025 | |
| Cardiva Medical, INC. | $136.24 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Scpharmaceuticals INC. | $134.50 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.63 | 2021-2025 | |
| Pfizer INC. | $111.52 | 2022-2025 | |
| Biosense Webster, INC. | $91.38 | 2025 | Carto 3 |
| Pulmonx Corporation | $62.73 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Inspire Medical Systems, INC. | $61.87 | 2024-2025 | Inspire |
| Angiodynamics, INC. | $53.14 | 2022 | |
| Sanofi-Aventis U.S. LLC | $48.47 | 2019-2024 | |
| Chiesi USA, INC. | $46.91 | 2019-2022 | |
| Esperion Therapeutics, INC. | $38.12 | 2021-2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $34.83 | 2024 | Opsumit, Uptravi |
| Gilead Sciences, INC. | $34.38 | 2019 | |
| Althera Pharmaceuticals LLC | $33.11 | 2022 | |
| Kestra Medical Technology Services, INC. | $27.87 | 2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $24.56 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lexicon Pharmaceuticals, INC. | $22.10 | 2023 | Inpefa |
| Medtronic Vascular, INC. | $21.61 | 2020 | |
| Astellas Pharma US INC | $20.36 | 2019 | |
| Cvrx, INC. | $19.68 | 2024 | Barostim Neo System |
| Azurity Pharmaceuticals, INC. | $18.99 | 2024 | Edarbi |
| Innovation Technologies INC | $15.19 | 2025 | Irrisept |
| Biogen, INC. | $15.15 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.52 | 2019 | |
| Agepha Pharma Fz LLC | $13.02 | 2024 | Lodoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Maniar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.